Biotech Startups

Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.

2 investors

Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an orally administered antiviral targeting rhinovirus infections in patients with chronic lung diseases such as COPD and asthma. The drug aims to stop viral infections before they trigger acute respiratory exacerbations, addressing the underlying viral cause rather than downstream inflammation.

2 investors

2 investors

Amadix develops blood-based diagnostic tests for early cancer detection before symptoms appear. The company focuses on non-invasive liquid biopsy technology to identify tumors years earlier than traditional methods.

2 investors

Amaryllis Tx develops tissue-targeted drug delivery by mapping tissue-specific glycan signatures and designing peptides that recognize them, using in silico and in vivo screening. Its lead peptide enables subcutaneously injected payloads such as antibodies, mRNA, ASO, and siRNA to cross the blood-brain barrier, initially targeting the brain.

2 investors

Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source. It serves researchers, life science companies, and research institutions through an app, API, and MCP interface, with each claim traceable to underlying evidence.

2 investors

Ambros Therapeutics is a therapeutics company.

2 investors

Ambrosia Bio produces rare sugars such as Allulose as low- to no-calorie replacements for sugar, offering a similar taste, sweetness, and textural profile without artificial aftertaste. Its portfolio is intended for food producers seeking sugar alternatives and is stated to be safe for diabetic use.

2 investors

Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.

2 investors

Amino Labs produces hands-on biotechnology experiment kits designed to teach genetic engineering and bacterial transformation to beginners in educational and hobbyist settings. The kits enable students and DIY biology enthusiasts to perform genetic engineering experiments on bacteria and learn foundational concepts in biotechnology.

2 investors

Amnova Biotech develops injectable therapies derived from amniotic biomaterials to promote heart regeneration following ischemic injury. The company targets cardiac regenerative medicine and is advancing its lead therapies from preclinical validation toward clinical application.

2 investors

AmphiStar develops biosurfactants through advanced bioprocessing and fermentation for industrial applications including chemicals and consumer goods. The company focuses on bio-based alternatives to conventional surfactants, serving industries seeking sustainable biochemical solutions.

2 investors

Life sciences platform accelerating development of next-generation therapies

2 investors

AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.

2 investors

AMW GmbH is a specialty pharmaceutical company that develops biodegradable drug delivery systems for controlled release of medications, with production facilities in Germany. It has two approved implant products, Goserelin and Leuprorelin, distributed worldwide through local and global pharmaceutical partners.

2 investors

Amyriad Therapeutics develops disease-modifying therapies for Alzheimer's disease, with a lead candidate called Ismidenon that employs novel cholinergic enhancement mechanisms. The company is led by neuroscientists and clinical experts focused on restoring cognitive function in aging-related neurodegeneration.

2 investors

AnaBios generates predictive human data for pharmaceutical drug development, using authentic human cells and tissues from healthy and diseased donors to assess drug efficacy and toxicity before clinical trials. It offers human tissue procurement and functional assay services, including gene expression, proteomic, and metabolomic profiling, to support drug discovery and preclinical safety testing.

2 investors

AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders. It is a publicly traded biotech company running with fewer than ~10 contractors.

2 investors

AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.

2 investors

Ancora Biotech is a privately held biotherapeutics developer overseeing the manufacturing and clinical development of three multi-specific antibodies held in separate spin-offs. Its programs target B cell cancers, inflammatory and metabolic disorders, and chronic hepatitis B infections.

2 investors

ANI.AI is a San Francisco research lab building a computational platform for longevity medicine that integrates deep multiomics, longitudinal digital phenotyping, and physician-supervised intervention into a unified model of an individual's biological state. It runs the ELITE healthspan intervention trial and an intervention layer (AgeBiotics) to make individual response to aging interventions measurable, working with research groups and clinical teams studying aging, cognition, muscle, immunity, metabolism, and microbiome.

2 investors

ANI Pharmaceuticals is a generic and specialty pharmaceutical company that develops, manufactures, and distributes prescription drugs across multiple therapeutic areas including generics, rare diseases, and established branded products.

2 investors

Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases. It uses a technology platform to discover active pharmaceutical ingredients designed for veterinary patients.

2 investors

Anodyne Chemistries produces formic acid, formaldehyde, and methanol through enzymatic conversion of CO2, offering multiple purity grades for industrial purchase.

2 investors